Valuation Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 30/07/2026 +04			5-day change	1st Jan Change
28.52 ^USD	-1.66%		+0.55%	-7.40%

07-24	Wall Street's Three-Front Squeeze
07-24	One hundred dollars and a market beating

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	172,063	192,229	140,770	94,810	124,862	114,621	-	-
Change	-	11.72%	-26.77%	-32.65%	31.7%	-8.2%	-	-
Enterprise Value (EV) ¹	152,725	169,905	112,635	73,709	114,029	134,023	126,440	114,005
Change	-	11.25%	-33.71%	-34.56%	54.7%	17.53%	-5.66%	-9.83%
P/E	57.8x	35.2x	32.6x	12.3x	20.9x	24.4x	16.9x	11.4x
PBR	7.82x	7.07x	4.5x	2.68x	3.47x	2.77x	2.38x	1.98x
PEG	-	0.4x	-1.5x	0.1x	-1x	-1.2x	0.4x	0.2x
Capitalization / Revenue	20.3x	13.2x	8.54x	4.4x	5.31x	4.06x	3.45x	2.85x
EV / Revenue	18x	11.6x	6.84x	3.42x	4.85x	4.74x	3.81x	2.83x
EV / EBITDA	46.8x	25.3x	20.1x	10.4x	15.9x	15.4x	10.8x	6.86x
EV / EBIT	50.6x	26.7x	21.2x	10.5x	17x	17.4x	12.6x	8.02x
EV / FCF	77.3x	47.3x	16.1x	9.72x	15.7x	24.9x	14.8x	8.15x
FCF Yield	1.29%	2.12%	6.23%	10.3%	6.36%	4.02%	6.74%	12.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	45.54	83.65	66.02	121.4	97.08	76.56	110.2	164.2
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	8,482	14,595	16,474	21,526	23,497	28,246	33,177	40,279
EBITDA ¹	3,266	6,719	5,616	7,116	7,175	8,691	11,694	16,627
EBIT ¹	3,018	6,357	5,321	7,003	6,727	7,708	10,033	14,217
Net income ¹	3,008	5,522	4,352	7,844	6,083	4,815	7,054	10,606
Net Debt ¹	-19,338	-22,324	-28,135	-21,101	-10,833	19,402	11,819	-616.3
Reference price ²	2,630.00	2,941.00	2,155.00	1,492.50	2,027.00	1,867.00	1,867.00	1,867.00
Nbr of stocks (in thousands)	65,423	65,362	65,322	63,524	61,599	61,393	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	12/02/25	17/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ARGENX SE	32.44x	8.02x	24.72x	0.05%	55.01B
WUXI APPTEC CO., LTD.	20.35x	6.27x	13.72x	1.56%	54.24B
BIONTECH SE	-18.46x	4.46x	-7.81x	-.--%	23.38B
INSMED INCORPORATED	-40.77x	12.94x	-38.12x	-.--%	22.57B
WUXI BIOLOGICS (CAYMAN) INC.	25.4x	4.97x	13.15x	-.--%	20.19B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-778.79x	36.99x	-4163.86x	-.--%	15.5B
PHARMAESSENTIA CORPORATION	42.81x	17.28x	44.49x	0.09%	14.2B
EXELIXIS, INC.	17.78x	5.16x	12.03x	-.--%	14.2B
MADRIGAL PHARMACEUTICALS, INC.	-76.56x	7.92x	-63.18x	-.--%	12.42B
Average	-86.20x	11.56x	-462.76x	0.19%	25.75B
Weighted average by Cap.	-43.64x	9.79x	-272.74x	0.38%